Table 4.
CNV data for all groups at pre, post and follow-up measurement
| Pre-treatment amplitude in μV (SD) | Post-treatment amplitude in μV (SD) | Follow-up amplitude in μV (SD) | |||
|---|---|---|---|---|---|
| iCNV | Migraine | + PMR | −11.46 (4.79) | −8.68 (3.54) | −8.5 (4.88) |
| − PMR | −11.81 (6.4) | −11.22 (4.85) | −11.19 (5.1) | ||
| Healthy | + PMR | −8.19 (3.25) | −8.66 (4.35) | −8.72 (3.58) | |
| − PMR | −8.97 (5.18) | −7.76 (5.13) | −7.24 (5.64) | ||
| oCNV | Migraine | + PMR | −8.58 (2.26) | −6.59 (1.93) | −6.28 (2.41) |
| − PMR | −8.72 (3) | −7.08 (2.07) | −6.71 (2.55) | ||
| Healthy | + PMR | −6.3 (2.23) | −5.61 (4) | −6.3 (2.57) | |
| − PMR | −7.04 (2.73) | −5.6 (2.74) | −5.72 (3.72) | ||
| Habituation coefficient | Migraine | + PMR | 0.20 (1.28) | −0.31 (0.94) | 0.31 (0.58) |
| − PMR | −0.26 (0.87) | −0.18 (0.93) | 0.10 (0.87) | ||
| Healthy | + PMR | −0.03 (1.23) | 0.21 (0.85) | 0.08 (0.81) | |
| − PMR | 0.26 (1.01) | −0.01 (0.83) | −0.14 (0.82) | ||
μV microvolt, SD standard deviation